NCT05382533

Brief Summary

The proposed intervention study addresses the development and validation of nutritional concepts based on menu plans for patients with hypertriglyceridemia (triglycerides \> 1.5 mmol/l) and participants with impaired glucose tolerance/prediabetes (glucose \> 5.6 ≤ 7 mmol/l).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 16, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 19, 2022

Completed
11 days until next milestone

Study Start

First participant enrolled

May 30, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 14, 2022

Completed
Last Updated

February 6, 2023

Status Verified

February 1, 2023

Enrollment Period

3 months

First QC Date

May 16, 2022

Last Update Submit

February 2, 2023

Conditions

Keywords

triacylglcerides, glucose, HbA1c, body weight

Outcome Measures

Primary Outcomes (2)

  • Triacylglcerides, mmol/l (group A, B)

    Cardiovascular risk factor

    Change from baseline after 10 weeks

  • Fasting glucose, mmol/l (group C, D)

    Diabetes risk factor

    Change from baseline after 10 weeks

Secondary Outcomes (28)

  • Total cholesterol (mmol/l)

    Change from baseline after 10 weeks

  • HDL cholesterol (mmol/l)

    Change from baseline after 10 weeks

  • LDL cholesterol (mmol/l)

    Change from baseline after 10 weeks

  • Systolic pressure (mm Hg)

    Change from baseline after 10 weeks

  • Diastolic pressure (mm Hg)

    Change from baseline after 10 weeks

  • +23 more secondary outcomes

Other Outcomes (4)

  • Creatinine (mmol/l)

    Change from baseline after 10 weeks

  • Albumine (mg/l)

    Change from baseline after 10 weeks

  • Selenium (µmol/24 h)

    Change from baseline after 10 weeks

  • +1 more other outcomes

Study Arms (4)

Hypertriglyceridemia intervention (group A)

EXPERIMENTAL

* Carbohydrates: ≤ 50 en% (sucrose + glucose + fructose ≤ 10 en%, where sucrose ≤ 5 en% and fructose ≤ 20 g/d) * Fat: 30-35 En% * Protein: 20 En% * marine n3 PUFA (EPA/DHA): ≥ 4000 mg/d (10 g fish oil)

Dietary Supplement: Menu plans

Hypertriglyceridemia control (group B)

NO INTERVENTION

no menu plans, no study foods

Prediabetes intervention (group C)

EXPERIMENTAL

* Carbohydrates: 40 ± 2 En% * Sucrose + glucose + fructose ≤ 10 En% * Free sugars \< 5% of daily energy * Fat: 40 ± 2% * Protein: 20 ± 2 En% * n3 PUFA: ≥ 500 mg/d

Dietary Supplement: Menu plans

Prediabetes control (group D)

NO INTERVENTION

no menu plans, no study foods

Interventions

Menu plansDIETARY_SUPPLEMENT

The study participants in group A and C receive defined personal nutritional counselling every two weeks and they are provided with daily menu plans (isocaloric) with optimized nutrient profiles and chosen study products (plant oils, nuts mixture etc.) over the study period of 10 weeks.

Hypertriglyceridemia intervention (group A)Prediabetes intervention (group C)

Eligibility Criteria

Age30 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Voluntary participation with documented consent
  • Willingness and ability to adhere to study protocol
  • Volunteer test person (m/f) aged ≥ 30 years and ≤ 80 years
  • BMI: ≥ 20 ≤ 40 kg/m2
  • No or moderate alcohol consumption (≤ 2 glasses/week)
  • non-smoker (if possible)
  • Group A, B: triglycerides: \> 1.5 mmol/l
  • Group C, D: Fasting glucose: ≥ 5.6 ≤ 7 mmol/L

You may not qualify if:

  • Concomitant diseases:
  • Hypercholesterolemia (genetic defect / familial predisposition)
  • Diabetes mellitus
  • Thyroid dysfunction (hyper- or hypothyroidism)
  • Food intolerances/allergies to ingredients in the study foods
  • Medications: lipid-lowering drugs, glucocorticoids, oral medication for the treatment of type 1-4 diabetes mellitus, insulin injections
  • Dietary supplements: especially n-3 fatty acids, vitamin E
  • Extremely high physical activity (daily)
  • Alcohol abuse (daily)
  • (smokers) \[if there are not enough subjects available, at least 7 smokers should be included so that a statistical analysis is possible\]
  • Uncontrolled organic diseases
  • Alcohol, medication or drug abuse
  • Participation in other observational clinical studies during or 4 wk. before starting this study
  • Severe behavioral, emotional, or psychiatric problems that the investigator determined would result in non-compliance
  • Pregnancy, lactation and unsafe contraception
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Nutritional Sciences

Jena, Thuringia, 07743, Germany

Location

Related Links

MeSH Terms

Conditions

Body Weight

Interventions

Menu Planning

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Food ServicesFood IndustryIndustryTechnology, Industry, and AgricultureFood Service, HospitalDietary ServicesHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Christine A Dawczynski, PhD

    Friedrich Schiller University Jena

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: parallel design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

May 16, 2022

First Posted

May 19, 2022

Study Start

May 30, 2022

Primary Completion

August 31, 2022

Study Completion

December 14, 2022

Last Updated

February 6, 2023

Record last verified: 2023-02

Locations